Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study

Files

hdl_148366.pdf (402.63 KB)
  (Published version)

Date

2023

Authors

Arnautovska, U.
Vitangcol, K.
Kesby, J.P.
Warren, N.
Rossell, S.L.
Neill, E.
Harris, A.
Galletly, C.
Castle, D.
Siskind, D.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Schizophrenia Research: Cognition, 2023; 33:100283-1-100283-7

Statement of Responsibility

Urska Arnautovska, Kathryn Vitangcol, James P. Kesby, Nicola Warren, Susan L. Rossell, Erica Neill, Anthony Harris, Cherrie Galletly, David Castle Dan Siskind

Conference Name

Abstract

Objective: In the general population, repeated cognitive testing produces learning effects with potential for improved test performance. It is currently unclear whether the same effect of repeated cognitive testing on cognition pertains to people living with schizophrenia, a condition often associated with significant cognitive impairments. This study aims to evaluate learning ability in people with schizophrenia and—considering the evidence that antipsychotic medication can additionally impair cognitive performance—explore the potential impact of anticholinergic burden on verbal and visual learning. Method: The study included 86 patients with schizophrenia, treated with clozapine, who had persisting negative symptoms. They were assessed at baseline, weeks 8, 24 and 52 using Positive and Negative Syndrome Scale, Hopkins Verbal Learning Test–Revised (HVLT-R) and Brief Visuospatial Memory Test-R (BVMT-R). Results: There were no significant improvements in verbal or visual learning across all measurements. Neither the clozapine/norclozapine ratio nor anticholinergic cognitive burden significantly predicted participants' total learning. Premorbid IQ was significantly associated with verbal learning on the HVLT-R. Conclusions: These findings advance our understanding of cognitive performance in people with schizophrenia and demonstrate limited learning performance in individuals with treatment-refractory schizophrenia.

School/Discipline

Dissertation Note

Provenance

Description

Available online 28 March 2023

Access Status

Rights

© 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

License

Call number

Persistent link to this record